Clinical trial
Injectable Naltrexone Treatment of Alcohol Dependence in Serious Mental Illness…
NCT00453609 · State University of New York - Upstate Medical University, Other · Completed
Key facts
| NCT number | NCT00453609 |
|---|---|
| Title | Injectable Naltrexone Treatment of Alcohol Dependence in Serious Mental Illness (SMI) |
| Official title | Injectable Naltrexone Treatment of Alcohol Dependence in Serious Mental Illness (SMI): An Open Prospective Pilot Trial |
| Acronym | vivitrol |
| Lead sponsor | State University of New York - Upstate Medical University, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia, Schizoaffective Disorder, Bipolar Disorder, Alcohol Dependence |
| Intervention type | Drug |
| Interventions | long-lasting injectable naltrexone |
| Enrollment | 15 |
| Start date | Apr 1, 2007 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Mar 29, 2007 |
| Last update posted | Dec 11, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: